matech10qa063008.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

Form 10-Q/A

(Mark One)

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2008

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________.

Commission file number: 33-23617

Matech Corp
Formerly Material Technologies, Inc.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)

95-4622822
(I.R.S. Employer
Identification No.)

11661 San Vicente Boulevard, Suite 707, Los Angeles, CA 90049
(Address of principal executive offices)

(310) 208-5589
(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes R   No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of large accelerated filer,” accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
o
 
Accelerated filer
o
Non-accelerated filer
o
 
Smaller reporting company
R

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o  No R

As of August 15, 2008, there were 194,459,421 shares of our Class A common stock issued and outstanding.

 
 

 

MATERIAL TECHNOLOGIES, INC.

TABLE OF CONTENTS
 
 
1
   
1
   
1
   
3
   
4
   
7
   
34
  
 
41
  
 
41
  
 
43
  
 
44
  
 
44
  
 
45
  
 
45
  
 
46
  
 
46
  
 
46
  
 
46
   
47
 

 
i


PART I – FINANCIAL INFORMATION

Item 1.       Financial Statements
 
 
MATERIAL TECHNOLOGIES, INC.
     
(A Development Stage Company)
     
       
CONDENSED CONSOLIDATED BALANCE SHEET
 
       
   
June 30,
 
   
2008
 
   
(Unaudited)
 
ASSETS
     
       
Current assets:
     
Cash and cash equivalents
  $ 530,045  
Inventories
    148,964  
Prepaid expenses and other current assets
    62,941  
         
Total current assets
    741,950  
         
Property and equipment, net
    89,632  
Intangible assets, net
    2,302  
Deposit
    2,348  
         
    $ 836,232  
 
 
 
 
 
 
 
 
 
 
 
Continued .. . .

1


MATERIAL TECHNOLOGIES, INC.
     
(A Development Stage Company)
     
       
CONDENSED CONSOLIDATED BALANCE SHEET - Continued
 
       
   
June 30,
 
   
2008
 
   
(Unaudited)
 
   
(Restated)
 
LIABILITIES AND STOCKHOLDERS'  DEFICIT
     
       
Current liabilities:
     
Accounts payable and accrued expenses
  $ 470,017  
Current portion of research and development sponsorship payable
    25,000  
Notes payable
    67,573  
Total current liabilities
    562,590  
         
Accrued legal settlement
    250,000  
Research and development sponsorship payable, net of current portion
    784,100  
Convertible debentures and accrued interest payable, net of discount
    270,973  
Notes payable, long-term
    222,110  
Derivative and warrant liabilities
    75,760,425  
      77,287,608  
         
Total liabilities
    77,850,198  
         
Minority interest in consolidated subsidiary
    825  
         
Commitments and contingencies
       
         
Stockholders' deficit:
       
Class A preferred stock, $0.001 par value, liquidation preference
       
of  $720 per share; 350,000 shares authorized; 337 shares issued
       
and outstanding as of June 30, 2008
    -  
Class B preferred stock, $0.001 par value, liquidation preference of
       
$10,000 per share; 15 shares authorized;  none issued and
       
outstanding as of June 30, 2008
    -  
Class C preferred stock, $0.001 par value, liquidation preference of
       
$0.001 per share; 25,000,000 shares authorized; 1,517 shares issued
       
and outstanding as of June 30,2008
    1  
Class D preferred stock, $0.001 par value, liquidation preference of
       
$0.001 per share; 20,000,000 shares authorized; none shares issued
       
and outstanding as of June 30,2008
    -  
Class E  convertible preferred stock, $0.001 par value, no liquidation
       
preference; 60,000 shares authorized; 53,700 shares issued and
       
outstanding as of June 30,2008
    54  
Class A Common Stock, $0.001 par value, 600,000,000 shares
       
authorized; 168,499 shares issued and 149,330 shares outstanding
       
at June 30,2008
    149  
Class B Common Stock, $0.001 par value, 600,000 shares authorized,
       
issued and outstanding as of June 30,2008
    600  
Warrants subscribed
    10,000  
Additional paid-in-capital
    326,904,859  
Deficit accumulated during the development stage
    (403,834,055 )
Treasury stock ( 293 shares at cost at June 30, 2008)
    (96,399 )
         
Total stockholders' deficit
    (77,014,791 )
         
    $ 836,232  
 
See accompanying notes to the condensed consolidated financial statements.
 
2

 
MATERIAL TECHNOLOGIES, INC.
                             
(A Development Stage Company)
                             
                               
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
                               
                           
From October 21, 1983
 
   
For the Three Months Ended
   
For the Six Months Ended
   
(Inception)
 
   
June 30,
   
June 30,
   
through
 
   
2007
   
2008
   
2007
   
2008
   
June 30, 2008
 
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
 
         
(Restated)
         
(Restated)
   
(Restated)
 
Revenues:
                             
Research and development
  $ -     $ -     $ -     $ -     $ 5,392,085  
Revenue from bridge testing
    22,778               66,745       1,090       319,714  
Other
    -       -       -       -       274,125  
                                         
Total revenues
    22,778       -       66,745       1,090       5,985,924  
                                         
Costs and expenses:
                                       
Research and development
    3,294,575       150,847       3,512,076       309,840       20,872,829  
General and administrative
    41,016,474       5,517,443       62,475,638       25,845,768       329,341,009  
Modification of research and development sponsorship agreement
    -       -       -       -       5,963,120  
Loss on settlement of lawsuits
    -       -       -       -       1,267,244  
                                         
Total costs and expenses
    44,311,049       5,668,290       65,987,714       26,155,608       357,444,202  
                                         
Loss from operations
    (44,288,271 )     (5,668,290 )     (65,920,969 )     (26,154,518 )     (351,458,278 )
                                         
Other income (expense):
                                       
Loss on modification of convertible debt
    -       (964,730 )     -       (964,730 )     (378,485 )
Loss on subcription receivables
                                    (1,368,555 )
Interest expense
    (612,416 )     (606,028 )     (1,590,651 )     (977,019 )     (12,717,212 )
Other-than-temporary impairment of marketable securities available for sale
            -                       (9,785,947 )
Net unrealized and realized loss of marketable securities
    (8,556,211 )             (8,556,219 )     (8 )     (9,398,226 )
Change in fair value of investments derivative liability
    -       -       -       -       (210,953 )
Change in fair value of derivative and warrant liabilities
    6,942,597       (71,103,676 )     22,920,017       (62,544,101 )     (18,957,012 )
Interest income
    12,594       3,080       15,966       15,523       482,405  
Other
    -       -       -       -       (25,992 )
                                         
Other income (expense), net
    (2,213,436 )     (72,671,354 )     12,789,113       (64,470,335 )     (52,359,977 )
                                         
Loss before provision for income taxes
    (46,501,707 )     (78,339,644 )     (53,131,856 )     (90,624,853 )     (403,818,255 )
                                         
Provision for income taxes
    -       -       (800 )     (800 )     (15,800 )
                                         
Net loss
  $ (46,501,707 )   $ (78,339,644 )   $ (53,132,656 )   $ (90,625,653 )   $ (403,834,055 )
                                         
Per share data:
                                       
Basic and diluted net loss per share
  $ (448.38 )   $ (500.20 )   $ (580.45 )   $ (614.04 )        
Weighted average Class A common shares outstanding - basic and diluted
    103,710       156,617       91,538       147,589          
 
 
 
 
See accompanying notes to the condensed consolidated financial statements.
 
3

 
MATERIAL TECHNOLOGIES, INC.
                 
(A Development Stage Company)
                 
                   
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
                   
               
From October 21, 1983
 
   
For the Six Months Ended
   
(Inception)
 
   
June 30,
   
through
 
   
2007
   
2008
   
June 30, 2008
 
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
 
         
(Restated)
   
(Restated)
 
                   
Cash flows from operating activities:
                 
Net loss
  $ (53,132,656 )   $ (90,625,653 )   $ (403,834,055 )
Adjustments to reconcile net loss to net cash used in operating activities:
                       
Loss on modification of convertible debt
    -       964,730       378,485  
Impairment loss
    19,255,875       -       21,391,528  
Loss on charge off of subscription receivables
    -               1,368,555  
Issuance of common stock for services
    15,558,944       3,625,200       210,110,040  
Increase in debt for services and fees
    -       1,100,000       5,556,625  
Officer's stock based compensation
    30,000,000       19,885,333       86,460,675  
Issuance of common stock for modification of research and development sponsorship agreement
    -               7,738,400  
Change in fair value of derivative and warrant liabilities
                    (41,351,889 )
Net realized and unrealized loss on marketable securities
    8,556,200               7,895,705  
Other-than-temporary impairment of marketable securities available for sale
    -               9,785,946  
Legal fees incurred for note payable
                    1,456,142  
Accrued interest expense added to principal
    156,901       135,816       1,630,821  
Amortization of discount on convertible debentures
    1,431,081       824,072       10,930,350  
Change in fair value of investments derivative liability
    (22,920,017 )     62,544,101       65,767,423  
Accrued interest income added to principal
    (5,428 )     25,433       (279,565 )
Depreciation and amortization
    1,951       10,621       238,405  
Other non-cash adjustments
    -               (114,730 )
(Increase) decrease in trade receivables
    91,787       108,661       (50,328 )
(Increase) decrease in inventories
    -       (86,748 )     (148,964 )
(Increase) decrease in prepaid expenses and other current assets
    (22,500 )     (17,257 )     225,316  
Increase in deposits
    -               (2,348 )
(Decrease) increase in accounts payable and accrued expenses
    (141,766 )     (130,968 )     2,377,927  
                         
Net cash used in operating activities
    (1,169,628 )     (1,636,659 )     (12,469,536 )
                         
                         
Cash flows from investing activities:
                       
Proceeds from the sale of marketable securities
    95,006       300,000       3,758,476  
Purchase of marketable securities
    (302,038 )     -       (2,206,379 )
Investment in certificate of deposits and commerical paper
    (700,177 )     (565,000 )     (1,965,000 )
Maturities of certificate of deposits and commercial paper
    -       1,565,000       1,965,000  
Payment received on officer loans
    -       3,803       880,058  
Funds advanced to officers
    -       -       (549,379 )
Proceeds received in acquisition of consolidated subsidiaries
                    600,000  
Purchase of property and equipment
    -       (17,167 )     (373,419 )
Investment in joint ventures
    -       -       (102,069 )
Proceeds from foreclosure
    -       -       44,450  
Proceeds from the sale of property and equipment
    -       -       19,250  
Payment for license agreement
    -       -       (6,250 )
                         
Net cash provided by (used in) investing activities
    (907,209 )     1,286,636       2,064,738  
 
Continued .. . .
 
4

 
 
MATERIAL TECHNOLOGIES, INC.
                 
(A Development Stage Company)
                 
                   
CONSOLIDATED STATEMENTS OF CASH FLOWS - Continued
 
                   
               
From October 21, 1983
 
   
For the Six Months Ended
   
(Inception)
 
   
June 30,
   
through
 
   
2007
   
2008
   
June 30, 2008
 
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
 
         
(Restated)
   
(Restated)
 
                   
Cash flow from financing activities:
                 
Proceeds from the sale of  common stock and warrants
  $ 2,850,000     $ 18,624     $ 9,464,577  
Proceeds from convertible debentures and other notes payable
    200,000       55,000       2,102,766  
Proceeds from the sale of preferred stock
    100,000       -       473,005  
Costs incurred in offerings
    (773,779 )     -       (1,130,932 )
Capital contributions
    -       -       301,068  
Purchase of treasury stock
    (17,381 )     (3,266 )     (170,641 )
Principal reduction on notes payable
    (26,671 )             (100,000 )
Payment on proposed reorganization
    -       -       (5,000 )
                         
Net cash provided by (used in) financing activities
    2,332,169       70,358       10,934,843  
                         
Net change in cash and cash equivalents
    255,332       (279,665 )     530,045  
                         
Cash and cash equivalents, beginning of period
    129,296       809,710       -  
                         
Cash and cash equivalents, end of period
  $ 384,628     $ 530,045     $ 530,045  
                         
Supplemental disclosure of cash flow information:
                       
Interest paid during the period
  $ 2,669     $ 281          
Income taxes paid during the period
  $ 800     $ 800          
 
Supplemental disclosures of non-cash investing and financing activities:
                 
2008
               
                 
During the six months ended June 30, 2008, the Company issued 4,230 shares of its Class A common shares in
the conversion of $491,132 of convertible debt.
 
                 
During the six months ended June 30, 2008, the Company issued 13,207 shares of its Class A common stock
for consulting  services valued at $3,668,400.
 
                 
During the six months ended June 30, 2008, the Company issued 378 shares of its Class A common stock
pursuant to the anti-dilution provisions of a settlement agreement.
                 
During the six months ended June 30, 2008. a former employee returned 450 shares of the Company's Class A
common stock to treasury which were subsequently cancelled.
                 
During the six months ended June 30, 2008. the Company's president returned 30,000 shares of the Company's
Class A common stock to treasury which were subsequently cancelled.
                 
During the six months ended June 30, 2008, the Company issued 34,500 shares of its Class A common stock
in consideration of the exercise of cashless warrants. The Company accrued derivative liability in connection with the
granting of the warrants, which had a balance of $1,151,900 on the date of exercise. The liability balance was credited to equity.
                 
During the six months ended June 30, 2008, the Company issued 78 shares of its Class A common stock for $18,624.
                 
During the six months ended June 30, 2008, the Company issued 1,040 shares of the Company's common stock
was issued through the conversion of 1,300 shares of the Company's Class E preferred shares.
                 
During the six months ended June 30, 2008, the Company contingent obligation to Mr. Beck under a settlement agreement
was reduced to $0, therefore the Company reduced its legal settlement liability by the remaining accrued provision of $230,000,
which was credited to equity.
           
                 
During the six months ended June 30, 2008, the Company obtained $55,000 through the issuance of convertible debt. In connection
with this debt, the Company recognized a beneficial conversion feature of $28,140 that was credited to equity.
 
 
Continued .. . .
 
 
 
During the six months ended June 30, 2008, the Company recognized compensation expense of $8,800 on the grant of
options to its employees and officers for the purchase of 800.000 shares of Class A common stock. In addition, during the six months
the Company granted options to its President for the purchase of 400,000,000 shares of its Class A common stock and  granted options
to a consultant to purchase 15,390,546 shares of its Class A common stock. The Company recognized a derivative liability of $6,400,000
on the granting of these options.
           
                 
2007
               
                 
During the six months ended June 30, 2007, the Company issued 2,839 shares of its Class A common stock
for consulting  services valued at $13,158,944.
 
                 
During the six months ended June 30, 2007, the Company received $1,000,000 in consideration of issuing 2,500 units.
Each unit consists of one share of the Company's Class A common stock and a warrant to purchase
one share of the Company's common stock at a price of $.60 per share. In connection with the private offering
the Company paid $239,065 in fees and issued warrants to purchase 2,118 shares of the Company's
common stock at a price of $1.20 per share.
 
                 
During the six months ended June 30, 2007, the Company issued 50,000 shares its Class E Series convertible
preferred stock in exchange for receiving all of the outstanding shares of Stress Analysis Technologies, Inc.  ("SATI").
The Company valued the acquisition at $19,355,875 of which $19,255,875 was allocated to the acquired license.
Durng the six months ended June 30, 2007, the Company deemed the license to be impaired and charged of the
$19,255,875 to operation. In connection with this transaction, the Company issued an additional 5,000 preferred
shares valued at $2,400,000 for fees in connection with the purchase. The $2,400,000 was charged to operations.
                 
During the  six months ended June 30, 2007, the Company issued 10,800 shares in escrow pursuant to an agreement it has with
with its convertible debenture holders. During 2007, 5,800 shares of Class A common stock was issued  to certain
debenture holders in the conversion of  $580,000 of indebtedness. In addition, for the redemption of 1,000 shares by certain debenture
holders, the balance due on the debentures  was increased by $600,000.
                 
During the six months ended June 30, 2007, the Company received 50 shares of prior issued common stock
which was subsequently cancelled.
           
 
 
 
 
 
 
 
 
 
 
 
 
 
See accompanying notes to the condensed consolidated financial statements.
6

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
NOTE 1 - BASIS OF PRESENTATION
 
1.  BASIS OF PRESENTATION
 
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations.

In the opinion of management, all adjustments, consisting of normal and recurring adjustments, necessary for a fair presentation of the financial position and the results of operations for the periods presented have been included.  The operating results of the Company on a quarterly basis may not be indicative of operating results for the full year.  For further information, refer to the financial statements and notes included in Material Technologies, Inc.’s (the Company’s) Form 10-KSB for the year ended December 31, 2007.
 
Reverse Stock Split
 
Effective on October 3, 2008, the Company declared a 1-for-1,000 reverse split of the Company’s Class A common stock. All share amounts and per share amounts have been adjusted throughout these financial statements for the reverse stock split.
 
Restatement of Financial Statements

The Company entered into an agreement with the Palisades convertible note holders to modify the terms of the convertible notes with an effective date of June 16, 2008 (See Note 9). In addition, effective on October 3, 2008, the Company declared a 1-for-1,000 reverse split of the Company’s Class A common stock. All share amounts and per share amounts have been adjusted throughout the financial statements for the reverse stock split.  Based upon these two reansactions. the Company has restated its financial statements for the three and six months ended June 30, 2008 as follows:

Statements of operations:
 
   
For the Three Months Ended
 
   
June 30, 2008
 
   
As Originally Stated
   
Adjustments
   
As Corrected
 
Revenues:
                 
Research and development
  $ -     $ -     $ -  
Revenue from bridge testing
    -               -  
Other
    -               -  
 
7

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
Total revenues
    -             -       -  
                               
Costs and expenses:
                             
Research and development
    150,847                     150,847  
General and administrative
    5,517,443                     5,517,443  
                               
Total costs and expenses
    5,668,290             -       5,668,290  
                               
Loss from operations
    (5,668,290 )           -       (5,668,290 )
                               
Other income (expense):
                             
Interest expense
    (397,973 )     1 )     (208,055 )     (606,028 )
Loss on modification of convertible debt
    -       2 )     (964,730 )     (964,730 )
Change in fair value of derivative liabilities
    (6,036,711 )     3 )     (65,066,965 )     (71,103,676 )
Interest income
    3,080                       3,080  
Other expense, net
    (6,431,604 )             (66,239,750 )     (72,671,354 )
                                 
Loss before provision for income taxes
    (12,099,894 )             (66,239,750 )     (78,339,644 )
                                 
Provision for income taxes
    -               -       -  
                                 
Net loss
  $ (12,099,894 )           $ (66,239,750 )   $ (78,339,644 )
                                 
Per share data:
                               
Basic and diluted net loss per share
  $ (77.26 )           $ (422.94 )   $ (500.20 )
  
                               
Weighted average Class A common shares outstanding - basic and diluted
    156,617               156,617       156,617  
 
1)  To record additional interest of $16,597 on the increased balance of debt and amortization of increased discount totalling $191,458.
2)  To record loss on modification of convertible debt.
3)  To expense increase in derivative liability due to the reduction in conversion price of convertible debt and granting of warrants to purchase 35M shares of common stock.
 
8

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007


   
For the Six Months Ended
 
   
June 30, 2008
 
   
As Originally Stated
         
Adjustments
   
As Corrected
 
Revenues:
                       
Research and development
  $ -             -     $ -  
Revenue from bridge testing
    1,090             -       1,090  
Other
    -             -       -  
                               
Total revenues
    1,090             -       1,090  
                               
Costs and expenses:
                             
Research and development
    309,840                     309,840  
General and administrative
    25,845,768                     25,845,768  
                               
Total costs and expenses
    26,155,608             -       26,155,608  
                               
Loss from operations
    (26,154,518 )           -       (26,154,518 )
                               
Other income (expense):
                             
Interest expense
    (768,964 )     1 )     (208,055 )     (977,019 )
Loss on modification of convertible debt
    -       2 )     (964,730 )     (964,730 )
Change in fair value of derivative liabilities
                               
Interest income
                            -  
Other expense, net
    -                       -  
Net unrealized and realized loss of marketable securities
    (8 )                     (8 )
Change in fair value of derivative liabilities
    2,522,864       3 )     (65,066,965 )     (62,544,101 )
Interest income
    15,523                       15,523  
      1,769,415               (66,239,750 )     (64,470,335 )
                                 
Loss before provision for income taxes
    (24,385,103 )             (66,239,750 )     (90,624,853 )
                                 
Provision for income taxes
    (800 )             -       (800 )
                                 
Net loss
  $ (28,200,501 )           $ (66,239,750 )   $ (90,625,653 )
                                 
Per share data:
                               
Basic and diluted net loss per share
  $ (0.31 )           $ (723.63 )   $ (990.04 )
  
                               
Weighted average Class A common shares outstanding - basic and diluted
    91,538               91,538       91,538  
 
1)  To record additional interest of $16,597 on the increased balance of debt and amortization of increased discount totaling $191,458.
2)  To record loss on modification of convertible debt.
3)  To expense increase in derivative liability due to the reduction in conversion price of convertible debt and granting of warrants to purchase 35M shares of common stock.
 
 
9

MATERIAL TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months and six months ended June 30, 2008 and 2007

 
Balance sheet: